Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

Share Price is delayed by 15 minutes
Get Live Data
3,970.00    -25.00 (-0.63%)
Bid:
3,930.00
Ask:
3,945.00
Spread: 15.00 (0.382%)
Market Cap: £1.23b
CGEO Live PriceLast checked at - London Stock Exchange

Intraday Georgia Capital Share Chart

Statement regarding recent media speculation

13 Jan 2025 07:00

RNS Number : 0559T
Georgia Capital PLC
13 January 2025
Β 

London, 13 January 2025

Β 

Β 

Statement regarding recent media speculation

Georgia Capital Plc's (GCAP) Board of Directors would like to address media speculation as reported late last week by Radio Liberty Georgia. The report speculated that certain members of the US House of Representatives have sent a letter to the new US administration calling for action against a list of 25 individuals, including GCAP's Chair and CEO, Irakli Gilauri, in relation to recent political events in Georgia.

The Board has no basis for assessing the origin of the list of names. We are, however, actively engaged in contacting the relevant US officials to clarify the circumstances. GCAP is a London listed public company whose main shareholders are predominantly US and European institutional investors. Mr. Gilauri leads the company in upholding the highest standards of corporate governance. We have a broad stakeholder base, and our policy has always been to not involve the company in the country's political process.

The Board has full confidence in Mr. Gilauri and rejects any suggestion that the US or any other government should be considering action against him. We are confident that, when furnished with relevant information, the responsible authorities would reach the same conclusion.

GCAP, in continuing to maintain the highest standards of governance, will take every necessary action to respond to unwarranted accusations against the company and Mr. Gilauri.

Β 

Β 

Β 

Β 

Name of authorised official of issuer responsible for making notification: Michael Oliver, Adviser to the Chairman & CEO.

About Georgia Capital PLC

Georgia Capital (LEI: 213800Q65T5GNBOW7H65) is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Company's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) an insurance business (P&C and medical insurance), (iii) a hospitals business, (iv) a renewable energy business (hydro and wind assets), (v) an education business and (vi) a clinics and diagnostics business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20% equity stake in the water utility business and a c.20% equity stake in LSE listed Bank of Georgia Group PLC ("BoG"), the holding company of leading universal banks in Georgia and Armenia.

JSC Georgia Capital has, as of the date hereof, the following credit rating:

S&P Global

'BB-'/FC & 'BB-'/LC

Β For further information, please visit www.georgiacapital.ge or contact:

Β 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
SPCSFWSLDEISESF
Date   Source Headline
16th May 20254:38 pmRNSTransaction in Own Shares
15th May 20254:30 pmRNSTransaction in Own Shares
14th May 20252:47 pmRNSTransaction in Own Shares
13th May 20254:40 pmRNSTransaction in Own Shares
12th May 20254:31 pmRNSTransaction in Own Shares
9th May 20255:18 pmRNSTransaction in Own Shares
8th May 202512:46 pmRNSTransaction in Own Shares
7th May 20253:03 pmRNSTransaction in Own Shares
7th May 20257:00 amRNS1st Quarter Results
6th May 20254:35 pmRNSTransaction in Own Shares
2nd May 20255:16 pmRNSTransaction in Own Shares
1st May 20254:56 pmRNSTransaction in Own Shares
1st May 202510:09 amRNSTotal Voting Rights
30th Apr 20254:32 pmRNSTransaction in Own Shares
29th Apr 20255:16 pmRNSTransaction in Own Shares
29th Apr 20254:21 pmRNSCancellation of Treasury Shares
28th Apr 20255:11 pmRNSTransaction in Own Shares
25th Apr 20255:09 pmRNSTransaction in Own Shares
24th Apr 202512:40 pmRNSTransaction in Own Shares
24th Apr 20259:01 amRNSNotice of Results
23rd Apr 20254:35 pmRNSTransaction in Own Shares
22nd Apr 20255:21 pmRNSTransaction in Own Shares
17th Apr 20252:22 pmRNSTransaction in Own Shares
16th Apr 20254:43 pmRNSTransaction in Own Shares
15th Apr 20255:04 pmRNSTransaction in Own Shares
11th Apr 20255:06 pmRNSTransaction in Own Shares
11th Apr 20257:00 amRNSNotice of AGM
10th Apr 20255:01 pmRNSTransaction in Own Shares
9th Apr 20255:14 pmRNSTransaction in Own Shares
8th Apr 20255:16 pmRNSTransaction in Own Shares
8th Apr 20254:12 pmRNSDirector/PDMR Shareholding
8th Apr 202512:07 pmRNSDirector/PDMR Shareholding
7th Apr 20255:12 pmRNSTransaction in Own Shares
4th Apr 20255:17 pmRNSTransaction in Own Shares
3rd Apr 20255:17 pmRNSTransaction in Own Shares
2nd Apr 20255:19 pmRNSTransaction in Own Shares
1st Apr 20253:59 pmRNSTransaction in Own Shares
1st Apr 202512:39 pmRNSHolding(s) in Company
1st Apr 202510:56 amRNSTotal Voting Rights
31st Mar 20254:09 pmRNSTransaction in Own Shares
28th Mar 20255:18 pmRNSTransaction in Own Shares
28th Mar 202512:20 pmRNSCancellation of Treasury Shares
27th Mar 20254:05 pmRNSTransaction in Own Shares
26th Mar 20252:09 pmRNSTransaction in Own Shares
25th Mar 20255:18 pmRNSTransaction in Own Shares
24th Mar 20255:10 pmRNSTransaction in Own Shares
21st Mar 20255:08 pmRNSTransaction in Own Shares
21st Mar 20257:00 amRNSAnnual Financial Report
20th Mar 20255:25 pmRNSTransaction in Own Shares
19th Mar 20255:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.